131 related articles for article (PubMed ID: 7515417)
1. Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rats.
Yamamoto A; Umemori S; Muranishi S
J Pharm Pharmacol; 1994 Jan; 46(1):14-8. PubMed ID: 7515417
[TBL] [Abstract][Full Text] [Related]
2. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various absorption enhancers and their pulmonary toxicity in rats.
Yamamoto A; Okumura S; Fukuda Y; Fukui M; Takahashi K; Muranishi S
J Pharm Sci; 1997 Oct; 86(10):1144-7. PubMed ID: 9344172
[TBL] [Abstract][Full Text] [Related]
3. [Effects of protease inhibitors on intestinal absorption of insulin].
Liu H; Pan WS; Du R; Li XD; Tang R
Yao Xue Xue Bao; 2004 Feb; 39(2):140-3. PubMed ID: 15127624
[TBL] [Abstract][Full Text] [Related]
4. Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats.
Liu H; Tang R; Pan WS; Zhang Y; Liu H
J Pharm Pharmacol; 2003 Nov; 55(11):1523-9. PubMed ID: 14713363
[TBL] [Abstract][Full Text] [Related]
5. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human insulin microcrystals and their absorption enhancement by protease inhibitors in rat lungs.
Park SH; Kwon JH; Lim SH; Park HW; Kim CW
Int J Pharm; 2007 Jul; 339(1-2):205-12. PubMed ID: 17451895
[TBL] [Abstract][Full Text] [Related]
7. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats.
Yamamoto A; Taniguchi T; Rikyuu K; Tsuji T; Fujita T; Murakami M; Muranishi S
Pharm Res; 1994 Oct; 11(10):1496-500. PubMed ID: 7855059
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of insulin to proteolysis in rat lung homogenate and its protection from proteolysis by various protease inhibitors.
Fukuda Y; Tsuji T; Fujita T; Yamamoto A; Muranishi S
Biol Pharm Bull; 1995 Jun; 18(6):891-4. PubMed ID: 7550127
[TBL] [Abstract][Full Text] [Related]
9. Effects of surfactants and protease inhibitors on nasal absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats.
Machida M; Sano K; Arakawa M; Hayashi M; Awazu S
Biol Pharm Bull; 1994 Oct; 17(10):1375-8. PubMed ID: 7533020
[TBL] [Abstract][Full Text] [Related]
10. Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin.
Morishita M; Morishita I; Takayama K; Machida Y; Nagai T
Biol Pharm Bull; 1993 Jan; 16(1):68-72. PubMed ID: 7690292
[TBL] [Abstract][Full Text] [Related]
11. Use of protease inhibitors to improve calcitonin absorption from the small and large intestine in rats.
Tozaki H; Odoriba T; Iseki T; Taniguchi T; Fujita T; Murakami M; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1998 Aug; 50(8):913-20. PubMed ID: 9751457
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats.
Kimura T; Sato K; Sugimoto K; Tao R; Murakami T; Kurosaki Y; Nakayama T
Biol Pharm Bull; 1996 Jun; 19(6):897-900. PubMed ID: 8799497
[TBL] [Abstract][Full Text] [Related]
13. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats.
Morita T; Yamamoto A; Takakura Y; Hashida M; Sezaki H
Pharm Res; 1994 Jun; 11(6):909-13. PubMed ID: 7937534
[TBL] [Abstract][Full Text] [Related]
14. Effect of protease inhibitors on pulmonary bioavailability of therapeutic proteins and peptides in the rat.
Amancha KP; Hussain A
Eur J Pharm Sci; 2015 Feb; 68():1-10. PubMed ID: 25460544
[TBL] [Abstract][Full Text] [Related]
15. Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine.
Gotoh S; Nakamura R; Nishiyama M; Quan YS; Fujita T; Yamamoto A; Muranishi S
J Pharm Sci; 1996 Aug; 85(8):858-62. PubMed ID: 8863277
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic transfer of macromolecules after intrapulmonary administration in the presence or absence of various absorption enhancers in rats.
Muranishi S; Fujita T; Murakami M; Yamamoto A
Pharmazie; 1996 May; 51(5):331-6. PubMed ID: 8710955
[TBL] [Abstract][Full Text] [Related]
17. Effects of sodium glycocholate and protease inhibitors on permeability of TRH and insulin across rabbit trachea.
Morimoto K; Uehara Y; Iwanaga K; Kakemi M
Pharm Acta Helv; 2000 Apr; 74(4):411-5. PubMed ID: 10812942
[TBL] [Abstract][Full Text] [Related]
18. Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.
Fetih G; Habib F; Katsumi H; Okada N; Fujita T; Attia M; Yamamoto A
Drug Metab Pharmacokinet; 2006 Jun; 21(3):222-9. PubMed ID: 16858126
[TBL] [Abstract][Full Text] [Related]
19. Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide delivery from nonoral routes.
Yamamoto A; Hayakawa E; Lee VH
Life Sci; 1990; 47(26):2465-74. PubMed ID: 1702176
[TBL] [Abstract][Full Text] [Related]
20. Does bacitracin have an absorption-enhancing effect in the intestine?
Gotoh S; Nakamura R; Nishiyama M; Fujita T; Yamamoto A; Muranishi S
Biol Pharm Bull; 1995 May; 18(5):794-6. PubMed ID: 7493005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
